Juchuanli Tu

State Key Laboratory Of Genetic Engineering, Key Laboratory Of Breast Cancer In Shanghai, The Shanghai Key Laboratory Of Medical Epigenetics
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Tumor cell-derived N-acetyl-aspartyl-glutamate reshapes the tumor microenvironment to facilitate breast cancer metastasis.

Tumor cell-derived N-acetyl-aspartyl-glutamate reshapes the tumor microenvironment to facilitate breast cancer metastasis.

Journal: Science bulletin

Published: May 15, 2024

IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer.

IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer.

Journal: Cancer research

Published: November 01, 2023

SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1-Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBC.

SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1-Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBC.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 19, 2023

Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1.

Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1.

Journal: Protein & cell

Published: August 03, 2023

Discovery of a first-in-class ANXA3 degrader for the treatment of triple-negative breast cancer.

Discovery of a first-in-class ANXA3 degrader for the treatment of triple-negative breast cancer.

Journal: Acta pharmaceutica Sinica. B

Published: July 02, 2022

PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway.

PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway.

Journal: Signal transduction and targeted therapy

Published: June 06, 2022

The potential effects and mechanisms of breast inflammatory lesions on the occurrence and development of breast cancer.

The potential effects and mechanisms of breast inflammatory lesions on the occurrence and development of breast cancer.

Journal: Frontiers in oncology

Published: May 05, 2022

Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarization.

Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarization.

Journal: Journal for immunotherapy of cancer

Published: April 14, 2022

A-to-I nonsynonymous RNA editing was significantly enriched in the ubiquitination site and correlated with clinical features and immune response.

A-to-I nonsynonymous RNA editing was significantly enriched in the ubiquitination site and correlated with clinical features and immune response.

Journal: Scientific reports

Published: March 21, 2022

Single-cell transcriptomics reveal the heterogeneity and dynamic of cancer stem-like cells during breast tumor progression.

Single-cell transcriptomics reveal the heterogeneity and dynamic of cancer stem-like cells during breast tumor progression.

Journal: Cell death & disease

Published: January 20, 2021

TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer.

TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer.

Journal: Nature communications

Published: September 23, 2020

Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity.

Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity.

Journal: Seminars in cancer biology

Published: August 26, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026